Steven Cohen's HOLX Position Overview
Steven Cohen (via Point72 Asset Management, L.P.) currently holds 208,045 shares of Hologic, Inc. (HOLX) worth $15.5 M, representing 0.02% of the portfolio. First purchased in 2015-Q3, this long-term strategic position has been held for 31 quarters.
Based on 13F filings, Steven Cohen has maintained a strategic position in HOLX, demonstrating sustained confidence in this investment. Largest addition occurred in Q2 2018, adding 1.96 M shares. Largest reduction occurred in Q3 2018, reducing 2.01 M shares.
Analysis based on 13F filings available since 2013 Q2
Steven Cohen's Hologic (HOLX) Holding Value Over Time
Track share changes against reported price movement
Quarterly Hologic (HOLX) Trades by Steven Cohen
| Report Date | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q4 2025 | -1.18 M | Reduce 84.99% | 208,045 | $74.49 |
| Q3 2025 | +1.39 M | New Buy | 1.39 M | $67.49 |
| Q2 2024 | -607,471 | Sold Out | 0 | $0.00 |
| Q1 2024 | +181,728 | Add 42.68% | 607,471 | $77.96 |
| Q4 2023 | -1.48 M | Reduce 77.62% | 425,743 | $71.45 |
| Q3 2023 | +1.9 M | New Buy | 1.9 M | $69.40 |
| Q1 2022 | -526,700 | Sold Out | 0 | $0.00 |
| Q4 2021 | +515,400 | Add 4561.06% | 526,700 | $76.56 |
| Q3 2021 | -8,100 | Reduce 41.75% | 11,300 | $73.81 |
| Q2 2021 | +19,400 | New Buy | 19,400 | $66.70 |
| Q4 2020 | -778,744 | Sold Out | 0 | $0.00 |
| Q3 2020 | -403,769 | Reduce 34.14% | 778,744 | $66.47 |
| Q2 2020 | +1.1 M | Add 1409.85% | 1.18 M | $57.00 |
| Q1 2020 | -1.7 M | Reduce 95.60% | 78,320 | $35.10 |
| Q4 2019 | +1.55 M | Add 689.90% | 1.78 M | $52.21 |
| Q3 2019 | -831,317 | Reduce 78.69% | 225,171 | $50.49 |
| Q2 2019 | +708,361 | Add 203.48% | 1.06 M | $48.02 |
| Q1 2019 | -204,875 | Reduce 37.05% | 348,127 | $48.40 |
| Q4 2018 | +152,000 | Add 37.91% | 553,002 | $41.10 |
| Q3 2018 | -2.01 M | Reduce 83.36% | 401,002 | $40.98 |
| Q2 2018 | +1.96 M | Add 435.47% | 2.41 M | $39.75 |
| Q1 2018 | -856,179 | Reduce 65.55% | 450,000 | $37.36 |
| Q4 2017 | +242,094 | Add 22.75% | 1.31 M | $42.75 |
| Q3 2017 | +1.06 M | New Buy | 1.06 M | $36.69 |
| Q1 2017 | -1.14 M | Sold Out | 0 | $0.00 |
| Q4 2016 | -173,500 | Reduce 13.19% | 1.14 M | $40.12 |
| Q3 2016 | +599,900 | Add 83.82% | 1.32 M | $38.83 |
| Q2 2016 | +158,500 | Add 28.45% | 715,700 | $34.60 |
| Q1 2016 | -441,100 | Reduce 44.19% | 557,200 | $34.50 |
| Q4 2015 | +760,800 | Add 320.34% | 998,300 | $38.69 |
| Q3 2015 | +237,500 | New Buy | 237,500 | $39.13 |
Steven Cohen's Hologic Investment FAQs
Steven Cohen first purchased Hologic, Inc. (HOLX) in Q3 2015, acquiring 237,500 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Steven Cohen has held Hologic, Inc. (HOLX) for 31 quarters since Q3 2015.
Steven Cohen's largest addition to Hologic, Inc. (HOLX) was in Q2 2018, adding 2,409,618 shares worth $95.78 M.
According to the latest 13F filing for Q4 2025, Steven Cohen's firm, Point72 Asset Management, L.P., owns 208,045 shares of Hologic, Inc. (HOLX), valued at approximately $15.5 M.
As of the Q4 2025 filing, Hologic, Inc. (HOLX) represents approximately 0.02% of Steven Cohen's publicly disclosed stock portfolio, making it one of their key holdings.
Steven Cohen's peak holding in Hologic, Inc. (HOLX) was 2,409,618 shares, as reported at the end of Q2 2018.